L008-0195 Screening compound: N-[4-(morpholin-4-yl)phenyl]-4-[6-(piperidin-1-yl)pyridazin-3-yl]benzamide

L008-0195 Screening compound: N-[4-(morpholin-4-yl)phenyl]-4-[6-(piperidin-1-yl)pyridazin-3-yl]benzamide
L008-0195 Screening compound: N-[4-(morpholin-4-yl)phenyl]-4-[6-(piperidin-1-yl)pyridazin-3-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L008-0195
N-[4-(morpholin-4-yl)phenyl]-4-[6-(piperidin-1-yl)pyridazin-3-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L008-0195

Molecular Formula

C26H29N5O2 (C26 H29 N5 O2)

Compound Name

N-[4-(morpholin-4-yl)phenyl]-4-[6-(piperidin-1-yl)pyridazin-3-yl]benzamide

IUPAC name

N-[4-(morpholin-4-yl)phenyl]-4-[6-(piperidin-1-yl)pyridazin-3-yl]benzamide

SMILES

O=C(c(cc1)ccc1-c(cc1)nnc1N1CCCCC1)Nc(cc1)ccc1N1CCOCC1

InChI

InChI=1S/C26H29N5O2/c32-26(27-22-8-10-23(11-9-22)30-16-18-33-19-17-30)21-6-4-20(5-7-21)24-12-13-25(29-28-24)31-14-2-1-3-15-31/h4-13H,1-3,14-19H2,(H,27,32)

InChI Key

DMKDWDHGAMLTKR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27225941

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.165

Distribution Coefficient, logD

4.164

Water Solubility, LogSw

-4.15

Polar Surface Area

59.078

Acid Dissociation Constant (pKa)

11.11

Base Dissociation Constant (pKb)

4.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

L008-0195 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L008-0195 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L008-0195?
Check Price and Availability of L008-0195, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L008-0195 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L008-0195
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L008-0195
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L008-0195 available by request